Latrunculin A Primitive Streak Induction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in efficiently differentiating human pluripotent stem cells (hPSCs) into definitive endoderm, particularly at the early stages of differentiation, as failure to do so often results in poor outcomes and the generation of off-target contaminating cells.
Innovation Solution
The method involves differentiating hPSCs into primitive streak cells using culture medium containing Latrunculin A (LatA), which enhances the efficiency of primitive streak induction and subsequent commitment to definitive endoderm.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional differentiation methods are used to generate definitive endoderm from hPSCs, then the process can be completed, but the efficiency is low and off-target contaminating cells are generated
Solution Approach 1:
The patent applies preliminary action by treating hPSCs with Latrunculin A before the actual differentiation process to primitive streak and definitive endoderm. This pre-treatment modifies the cellular state in advance, making the cells more responsive to differentiation signals and improving both the efficiency and purity of the final definitive endoderm product. The LatA treatment is applied during the early stages of differentiation protocol, specifically in the media formulation for primitive streak induction.
Solution Approach 2:
The patent employs parameter changes by modifying the chemical composition of the differentiation media through the addition of Latrunculin A. This small molecule compound changes the biochemical parameters of the culture system, affecting cytoskeletal dynamics and signaling pathways to enhance the specification of definitive endoderm while suppressing off-target differentiation, thereby improving both productivity and reliability.
2Reliability
If differentiation protocols are optimized to improve outcomes, then the process complexity increases
Solution Approach 1:
The patent applies the taking out principle by extracting and isolating the critical factor (Latrunculin A) that drives efficient definitive endoderm formation. By identifying this single key component, the complex differentiation protocol is simplified into a more manageable process centered around LatA treatment, reducing the number of variables that need to be optimized while maintaining high reliability of differentiation outcomes.
Data Source
AI summary
There is described herein a method of producing primitive streak cells for differentiation to definitive endoderm from a population of human pluripotent stem cells (hPSCs), the method comprising: differentiating a population of hPSCs to primitive streak cells in culture medium comprising Latrunculin A (LatA).